1. Home
  2. ZEUS vs AKBA Comparison

ZEUS vs AKBA Comparison

Compare ZEUS & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEUS
  • AKBA
  • Stock Information
  • Founded
  • ZEUS 1954
  • AKBA 2007
  • Country
  • ZEUS United States
  • AKBA United States
  • Employees
  • ZEUS N/A
  • AKBA N/A
  • Industry
  • ZEUS Metal Fabrications
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEUS Industrials
  • AKBA Health Care
  • Exchange
  • ZEUS Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • ZEUS 406.7M
  • AKBA 336.2M
  • IPO Year
  • ZEUS 1994
  • AKBA 2014
  • Fundamental
  • Price
  • ZEUS $39.64
  • AKBA $1.79
  • Analyst Decision
  • ZEUS
  • AKBA Strong Buy
  • Analyst Count
  • ZEUS 0
  • AKBA 2
  • Target Price
  • ZEUS N/A
  • AKBA $5.75
  • AVG Volume (30 Days)
  • ZEUS 102.9K
  • AKBA 2.8M
  • Earning Date
  • ZEUS 10-31-2024
  • AKBA 11-07-2024
  • Dividend Yield
  • ZEUS 1.51%
  • AKBA N/A
  • EPS Growth
  • ZEUS N/A
  • AKBA N/A
  • EPS
  • ZEUS 2.27
  • AKBA N/A
  • Revenue
  • ZEUS $2,012,296,000.00
  • AKBA $169,879,000.00
  • Revenue This Year
  • ZEUS N/A
  • AKBA N/A
  • Revenue Next Year
  • ZEUS $6.46
  • AKBA $6.13
  • P/E Ratio
  • ZEUS $17.43
  • AKBA N/A
  • Revenue Growth
  • ZEUS N/A
  • AKBA N/A
  • 52 Week Low
  • ZEUS $32.23
  • AKBA $0.80
  • 52 Week High
  • ZEUS $73.49
  • AKBA $2.48
  • Technical
  • Relative Strength Index (RSI)
  • ZEUS 52.83
  • AKBA 56.65
  • Support Level
  • ZEUS $38.43
  • AKBA $1.88
  • Resistance Level
  • ZEUS $42.56
  • AKBA $2.02
  • Average True Range (ATR)
  • ZEUS 1.77
  • AKBA 0.12
  • MACD
  • ZEUS 0.25
  • AKBA -0.00
  • Stochastic Oscillator
  • ZEUS 70.77
  • AKBA 46.34

About ZEUS Olympic Steel Inc.

Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: